These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1783568)

  • 1. Localization of donor nuclei in skeletal muscle grafts by in situ hybridization to a cDNA probe.
    Coulton GR; Skynner MJ; Smith T; Pagel CN; Partridge TA
    Histochem J; 1991 Jul; 23(7):323-7. PubMed ID: 1783568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ hybridisation of a Y chromosome-specific probe to male myoblasts after implantation into female skeletal muscle.
    Coulton G; Skynner M; Pagel C; Morgan J; Partridge T
    Biochem Soc Trans; 1991 Apr; 19(2):195S. PubMed ID: 1889574
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.
    Partridge TA; Morgan JE; Coulton GR; Hoffman EP; Kunkel LM
    Nature; 1989 Jan; 337(6203):176-9. PubMed ID: 2643055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts.
    Chen M; Li HJ; Fang Q; Goodwin TG; Florendo JA; Law PK
    Cell Transplant; 1992; 1(1):17-22. PubMed ID: 1344288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts.
    Huard J; Labrecque C; Dansereau G; Robitaille L; Tremblay JP
    Muscle Nerve; 1991 Feb; 14(2):178-82. PubMed ID: 2000106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients.
    Fanin M; Danieli GA; Vitiello L; Senter L; Angelini C
    Neuromuscul Disord; 1992; 2(1):41-5. PubMed ID: 1525557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control.
    Denetclaw WF; Bi G; Pham DV; Steinhardt RA
    Mol Biol Cell; 1993 Sep; 4(9):963-72. PubMed ID: 8257798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of individual myoblasts after transplantation into muscles of DMD patients.
    Gussoni E; Blau HM; Kunkel LM
    Nat Med; 1997 Sep; 3(9):970-7. PubMed ID: 9288722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery.
    Gross JG; Bou-Gharios G; Morgan JE
    Cell Tissue Res; 1999 Nov; 298(2):371-5. PubMed ID: 10571126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.
    Karpati G; Pouliot Y; Zubrzycka-Gaarn E; Carpenter S; Ray PN; Worton RG; Holland P
    Am J Pathol; 1989 Jul; 135(1):27-32. PubMed ID: 2672825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
    Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
    Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.
    Satoh A; Huard J; Labrecque C; Tremblay JP
    J Histochem Cytochem; 1993 Oct; 41(10):1579-82. PubMed ID: 8245416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice.
    Hagiwara Y; Mizuno Y; Takemitsu M; Matsuzaki T; Nonaka I; Ozawa E
    Acta Neuropathol; 1995; 90(6):592-600. PubMed ID: 8615079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
    Tidball JG; Spencer MJ; St Pierre BA
    Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice.
    Huard J; Tremblay G; Verreault S; Labrecque C; Tremblay JP
    Cell Transplant; 1993; 2(2):113-8. PubMed ID: 8143077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
    Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
    Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.